Skip to main content

Hls Therapeutics Inc(HLS-T)
TSX

Today's Change
Real-Time Last Update

HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call

Newswire.ca - Thu Feb 29, 5:30AM CST

TORONTO, Feb. 29, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q4 and fiscal 2023 financial results on Thursday, March 14, 2024. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will be hosted by Mr. Craig Millian, Chief Executive Officer and Mr. John Hanna, Interim Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast.

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe